Bioneer Corporation (KOSDAQ:064550)
14,290
+180 (1.28%)
Apr 1, 2025, 3:30 PM KST
Bioneer Revenue
Bioneer had revenue of 65.88B KRW in the quarter ending September 30, 2024, a decrease of -10.66%. This brings the company's revenue in the last twelve months to 287.66B, up 15.57% year-over-year. In the year 2023, Bioneer had annual revenue of 263.24B with 20.53% growth.
Revenue (ttm)
287.66B
Revenue Growth
+15.57%
P/S Ratio
1.24
Revenue / Employee
523.09M
Employees
562
Market Cap
364.18B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 263.24B | 44.84B | 20.53% |
Dec 31, 2022 | 218.39B | -5.35B | -2.39% |
Dec 31, 2021 | 223.74B | 16.76B | 8.10% |
Dec 31, 2020 | 206.99B | 170.70B | 470.33% |
Dec 31, 2019 | 36.29B | 12.21B | 50.73% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Biologics | 4,547.32B |
Celltrion | 3,557.30B |
ALTEOGEN | 102.85B |
Yuhan | 2,067.79B |
SK Biopharmaceuticals | 547.60B |
HLB Co., Ltd. | 51.92B |
Sam Chun Dang Pharm. | 210.92B |
PharmaResearch | 350.12B |